Cargando…

Correction to: Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy

Detalles Bibliográficos
Autores principales: Simmons, Aaron B., Bretz, Colin A., Wang, Haibo, Kunz, Eric, Hajj, Kassem, Kennedy, Carson, Yang, Zhihong, Suwanmanee, Thipparat, Kafri, Tal, Hartnett, M. Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208888/
https://www.ncbi.nlm.nih.gov/pubmed/29943214
http://dx.doi.org/10.1007/s10456-018-9626-5
_version_ 1783366801199988736
author Simmons, Aaron B.
Bretz, Colin A.
Wang, Haibo
Kunz, Eric
Hajj, Kassem
Kennedy, Carson
Yang, Zhihong
Suwanmanee, Thipparat
Kafri, Tal
Hartnett, M. Elizabeth
author_facet Simmons, Aaron B.
Bretz, Colin A.
Wang, Haibo
Kunz, Eric
Hajj, Kassem
Kennedy, Carson
Yang, Zhihong
Suwanmanee, Thipparat
Kafri, Tal
Hartnett, M. Elizabeth
author_sort Simmons, Aaron B.
collection PubMed
description
format Online
Article
Text
id pubmed-6208888
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-62088882018-11-09 Correction to: Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy Simmons, Aaron B. Bretz, Colin A. Wang, Haibo Kunz, Eric Hajj, Kassem Kennedy, Carson Yang, Zhihong Suwanmanee, Thipparat Kafri, Tal Hartnett, M. Elizabeth Angiogenesis Correction Springer Netherlands 2018-06-25 2018 /pmc/articles/PMC6208888/ /pubmed/29943214 http://dx.doi.org/10.1007/s10456-018-9626-5 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Correction
Simmons, Aaron B.
Bretz, Colin A.
Wang, Haibo
Kunz, Eric
Hajj, Kassem
Kennedy, Carson
Yang, Zhihong
Suwanmanee, Thipparat
Kafri, Tal
Hartnett, M. Elizabeth
Correction to: Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy
title Correction to: Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy
title_full Correction to: Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy
title_fullStr Correction to: Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy
title_full_unstemmed Correction to: Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy
title_short Correction to: Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy
title_sort correction to: gene therapy knockdown of vegfr2 in retinal endothelial cells to treat retinopathy
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208888/
https://www.ncbi.nlm.nih.gov/pubmed/29943214
http://dx.doi.org/10.1007/s10456-018-9626-5
work_keys_str_mv AT simmonsaaronb correctiontogenetherapyknockdownofvegfr2inretinalendothelialcellstotreatretinopathy
AT bretzcolina correctiontogenetherapyknockdownofvegfr2inretinalendothelialcellstotreatretinopathy
AT wanghaibo correctiontogenetherapyknockdownofvegfr2inretinalendothelialcellstotreatretinopathy
AT kunzeric correctiontogenetherapyknockdownofvegfr2inretinalendothelialcellstotreatretinopathy
AT hajjkassem correctiontogenetherapyknockdownofvegfr2inretinalendothelialcellstotreatretinopathy
AT kennedycarson correctiontogenetherapyknockdownofvegfr2inretinalendothelialcellstotreatretinopathy
AT yangzhihong correctiontogenetherapyknockdownofvegfr2inretinalendothelialcellstotreatretinopathy
AT suwanmaneethipparat correctiontogenetherapyknockdownofvegfr2inretinalendothelialcellstotreatretinopathy
AT kafrital correctiontogenetherapyknockdownofvegfr2inretinalendothelialcellstotreatretinopathy
AT hartnettmelizabeth correctiontogenetherapyknockdownofvegfr2inretinalendothelialcellstotreatretinopathy